Annual D&A
$10.10 K
+$3400.00+50.75%
31 December 2023
Summary:
Salarius Pharmaceuticals annual depreciation & amortization is currently $10.10 thousand, with the most recent change of +$3400.00 (+50.75%) on 31 December 2023. During the last 3 years, it has fallen by -$8000.00 (-44.20%). SLRX annual D&A is now -96.89% below its all-time high of $324.50 thousand, reached on 31 December 2017.SLRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1100.00
$0.000.00%
30 September 2024
Summary:
Salarius Pharmaceuticals quarterly depreciation & amortization is currently $1100.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$4500.00 (-80.36%). SLRX quarterly D&A is now -99.02% below its all-time high of $111.90 thousand, reached on 31 December 2016.SLRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$4400.00
-$4500.00-50.56%
30 September 2024
Summary:
Salarius Pharmaceuticals TTM depreciation & amortization is currently $4400.00, with the most recent change of -$4500.00 (-50.56%) on 30 September 2024. Over the past year, it has dropped by -$6300.00 (-58.88%). SLRX TTM D&A is now -98.79% below its all-time high of $362.50 thousand, reached on 30 September 2017.SLRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLRX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.8% | -80.4% | -58.9% |
| 3 y3 years | -44.2% | -77.1% | -77.8% |
| 5 y5 years | -95.6% | -73.8% | -97.5% |
SLRX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -47.4% | +50.8% | -80.4% | +173.3% | -77.8% | +22.2% |
| 5 y | 5 years | -95.6% | +50.8% | -80.4% | +173.3% | -97.5% | +22.2% |
| alltime | all time | -96.9% | +50.8% | -99.0% | +173.3% | -98.8% | +22.2% |
Salarius Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1100.00(0.0%) | $4400.00(-50.6%) |
| June 2024 | - | $1100.00(0.0%) | $8900.00(-6.3%) |
| Mar 2024 | - | $1100.00(0.0%) | $9500.00(-5.9%) |
| Dec 2023 | $10.10 K(+50.7%) | $1100.00(-80.4%) | $10.10 K(-5.6%) |
| Sept 2023 | - | $5600.00(+229.4%) | $10.70 K(+57.4%) |
| June 2023 | - | $1700.00(0.0%) | $6800.00(+88.9%) |
| Mar 2023 | - | $1700.00(0.0%) | $3600.00(-46.3%) |
| Dec 2022 | $6700.00(-65.1%) | $1700.00(0.0%) | $6700.00(-31.6%) |
| Sept 2022 | - | $1700.00(-213.3%) | $9800.00(-24.0%) |
| June 2022 | - | -$1500.00(-131.3%) | $12.90 K(-32.8%) |
| Mar 2022 | - | $4800.00(0.0%) | $19.20 K(0.0%) |
| Dec 2021 | $19.20 K(+6.1%) | $4800.00(0.0%) | $19.20 K(-3.0%) |
| Sept 2021 | - | $4800.00(0.0%) | $19.80 K(+3.1%) |
| June 2021 | - | $4800.00(0.0%) | $19.20 K(+3.2%) |
| Mar 2021 | - | $4800.00(-11.1%) | $18.60 K(+3.3%) |
| Dec 2020 | $18.10 K(-85.8%) | $5400.00(+28.6%) | $18.00 K(+7.1%) |
| Sept 2020 | - | $4200.00(0.0%) | $16.80 K(0.0%) |
| June 2020 | - | $4200.00(0.0%) | $16.80 K(-82.3%) |
| Mar 2020 | - | $4200.00(0.0%) | $95.10 K(-25.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $127.40 K(-44.2%) | $4200.00(0.0%) | $127.40 K(-26.9%) |
| Sept 2019 | - | $4200.00(-94.9%) | $174.40 K(-21.9%) |
| June 2019 | - | $82.50 K(+126.0%) | $223.20 K(+11.3%) |
| Mar 2019 | - | $36.50 K(-28.7%) | $200.60 K(-12.1%) |
| Dec 2018 | $228.20 K(-29.7%) | $51.20 K(-3.4%) | $228.20 K(-9.1%) |
| Sept 2018 | - | $53.00 K(-11.5%) | $251.00 K(-9.5%) |
| June 2018 | - | $59.90 K(-6.6%) | $277.50 K(-6.7%) |
| Mar 2018 | - | $64.10 K(-13.4%) | $297.30 K(-8.4%) |
| Dec 2017 | $324.50 K(+17.1%) | $74.00 K(-6.9%) | $324.60 K(-10.5%) |
| Sept 2017 | - | $79.50 K(-0.3%) | $362.50 K(+1.1%) |
| June 2017 | - | $79.70 K(-12.8%) | $358.40 K(+6.1%) |
| Mar 2017 | - | $91.40 K(-18.3%) | $337.80 K(+21.9%) |
| Dec 2016 | $277.20 K(+455.5%) | $111.90 K(+48.4%) | $277.20 K(+55.4%) |
| Sept 2016 | - | $75.40 K(+27.6%) | $178.40 K(+49.8%) |
| June 2016 | - | $59.10 K(+91.9%) | $119.10 K(+66.8%) |
| Mar 2016 | - | $30.80 K(+135.1%) | $71.40 K(+42.8%) |
| Dec 2015 | $49.90 K | $13.10 K(-18.6%) | $50.00 K(+35.5%) |
| Sept 2015 | - | $16.10 K(+41.2%) | $36.90 K(+77.4%) |
| June 2015 | - | $11.40 K(+21.3%) | $20.80 K(+121.3%) |
| Mar 2015 | - | $9400.00 | $9400.00 |
FAQ
- What is Salarius Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual D&A year-on-year change?
- What is Salarius Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly D&A year-on-year change?
- What is Salarius Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals TTM D&A year-on-year change?
What is Salarius Pharmaceuticals annual depreciation & amortization?
The current annual D&A of SLRX is $10.10 K
What is the all time high annual D&A for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual depreciation & amortization is $324.50 K
What is Salarius Pharmaceuticals annual D&A year-on-year change?
Over the past year, SLRX annual depreciation & amortization has changed by +$3400.00 (+50.75%)
What is Salarius Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of SLRX is $1100.00
What is the all time high quarterly D&A for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly depreciation & amortization is $111.90 K
What is Salarius Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, SLRX quarterly depreciation & amortization has changed by -$4500.00 (-80.36%)
What is Salarius Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of SLRX is $4400.00
What is the all time high TTM D&A for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM depreciation & amortization is $362.50 K
What is Salarius Pharmaceuticals TTM D&A year-on-year change?
Over the past year, SLRX TTM depreciation & amortization has changed by -$6300.00 (-58.88%)